Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CA |
First Approval Date31 Dec 1937 |
100 Clinical Results associated with Bausch & Lomb UK Holdings Ltd.
0 Patents (Medical) associated with Bausch & Lomb UK Holdings Ltd.
100 Deals associated with Bausch & Lomb UK Holdings Ltd.
100 Translational Medicine associated with Bausch & Lomb UK Holdings Ltd.